TERN-701

· Terns, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TERN-701, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) [Phase 1, Phase 2]

See pricing